Head and Neck Cancer

HEAD AND NECK CANCER ADVISOR

HEADLINES
TREATMENT REGIMENS
DRUG INFORMATION

FEATURED CONTENT

Many Immune Checkpoint Inhibitor Combination Therapies Show No Evidence of Drug Synergy

The efficacy of many combination therapies may be due to independent drug action, not synergistic or additive effects.
PTSD in Cancer Patients: What Providers Need to Know

Experts outline risk factors for PTSD and explain how PTSD can affect cancer outcomes.
How to Prevent a Cyberattack from Derailing Cancer Care

Cyberattacks on health care organizations may not be fully preventable, but there are ways to limit their impact on cancer care.
New Therapies on the Horizon for Elderly or Frail Patients With Head and Neck Cancer

A nanoparticle-radiotherapy regimen and a chemoimmunotherapy regimen both appear safe and effective for this population.
Blood-Based Test May Establish a ‘New Paradigm’ for Cancer Screening

The test can accurately detect cancer and predict where it is located, according to researchers.

HEAD AND NECK CANCER NEWS

Doctor checking on female patient with cancer.

Cancer Patients With HIV May Not Receive Equitable Treatment

August 4, 2022

Blood sample

Early Changes in ctDNA May Predict Treatment Outcomes in Advanced Cancer

July 29, 2022

Thyroid Cancer Often Detected in Asymptomatic Patients

July 26, 2022

Intratumoral Bacteria Could Be Used to Predict Outcomes of Nasopharyngeal Carcinoma

July 21, 2022

Blood type testing

Blood Type Linked to Outcomes of Immune Checkpoint Inhibitor Therapy in Metastatic Cancer

July 20, 2022

Next post in Head and Neck Cancer

HPV-Related Throat Cancer Outcomes in Men Vary by Race, Ethnicity